Transcatheter aortic valve implantation: safety and effectiveness of the treatment of degenerated aortic homograft

Revista Española De Cardiología
Diego López-OteroRamiro Trillo-Nouche

Abstract

Percutaneous aortic valve implantation for patients with severe symptomatic aortic stenosis and a high surgical risk is currently well established. We report our experience in terms of safety and effectiveness of transcatheter aortic valve implantation in other clinical context like the degenerated aortic homografts. We report our initial experience in four hospitals and five patients with degenerated aortic homograft and severe aortic regurgitation, refused for surgery for a heart team, that underwent percutaneous implantation of CoreValve(®) aortic prosthesis. We included three males and two females. The mean age was 70 (3.5) years. All patients were symptomatic in New York Heart Association class III or IV. Procedures were performed through one of the femoral arteries in all patients and under sedation in three patients. The implant was successfully carried out in all cases. There were no major complications during the procedure or admission and the valvular defect was solved in all cases. In-hospital and 30-days mortality was 0. All patients had clinical improvement during follow-up with a reduction in at less two grades in the New York Heart Association functional scale. In our experience the treatment of degenerated aorti...Continue Reading

References

Jul 1, 1968·Thorax·H Bentall, A De Bono
Feb 3, 2009·The Journal of Thoracic and Cardiovascular Surgery·Ayyaz AliJohn Pepper
Oct 22, 2010·The New England Journal of Medicine·Martin B LeonUNKNOWN PARTNER Trial Investigators
Jan 7, 2011·Revista española de cardiología·José M Hernández-GarcíaEduardo de Teresa-Galván
Jun 7, 2011·The New England Journal of Medicine·Craig R SmithUNKNOWN PARTNER Trial Investigators

❮ Previous
Next ❯

Citations

Apr 30, 2014·Revista Española De Cardiología·Federico A ParedesJuan Martínez-León
Apr 30, 2014·Revista Española De Cardiología·José M de la Torre HernándezJavier Goicolea Ruigomez
Apr 30, 2014·Revista Española De Cardiología·Rafael RomagueraAngel Cequier

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Related Papers

Arquivos brasileiros de cardiologia
Luís Roberto GerolaEnio Buffolo
Circulation
Diego Perez de ArenazaASSERT (Aortic Stentless versus Stented valve assessed by Echocardiography Randomized Trial) Investigators
© 2022 Meta ULC. All rights reserved